Delivery Order SPE2DB20D2104-SPE2DB25FMQAJ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Bicillin L-A 1,200,000 units in 2mL formulations, with a ceiling value of $1,443.54. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement from the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Bicillin L-A 1,200,000 units in 2ml formulations, with a ceiling value of $14,887.08. This competitively awarded, firm fixed-price delivery order is scheduled for completion by April 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's pharmaceutical supply relationship with...
- The Defense Logistics Agency awarded a delivery order valued at $1,443.54 to AmerisourceBergen Drug Corp for Bicillin L-A 1,200,000 units in 2ml vials. The contract is non-competitive with no set-aside designation and was awarded on July 14, 2025, with an ultimate completion date of July 15, 2025. This delivery order is issued under a firm fixed price arrangement with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order valued at $34,644.96 to AmerisourceBergen Drug Corp for the supply of Bicillin L-A 1,200,000 units (2mL vials). The contract is a firm fixed-price delivery order with no set-aside designation, reflecting AmerisourceBergen's competitive capability to serve federal medical procurement requirements. Performance will be completed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 3, 2025. This...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Bicillin L-A 1,200,000 Units 2ML, with a ceiling value of $5,709.85 and an ultimate completion date of June 2, 2025. This delivery order was competitively awarded with no set-aside designation and represents a procurement under the company's broader pharmaceutical supply agreement with DLA. The place of performance is AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Bicillin L-A 1,200,000 Units 2ML, an antibiotic pharmaceutical product. This firm fixed-price delivery order carries a ceiling value of $133,883.52 and is scheduled for ultimate completion by May 7, 2025. The contract represents a competitive award with no set-aside designation, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Bicillin L-A 1,200,000 units in 2ml formulations, with a ceiling value of $1,831.46. This competitively awarded, non-set-aside contract is classified as a delivery order with firm fixed pricing and is scheduled for completion by May 7, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,443.54 to AmerisourceBergen Drug Corp on June 10, 2025, for the supply of Bicillin L-A 1,200,000 units in 2mL formulations. The award is a firm fixed-price delivery order with an ultimate completion date of June 11, 2025, and represents a non-competitive, non-set-aside transaction. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency has awarded a delivery order valued at $1,443.54 to AmerisourceBergen Drug Corp for the supply of Bicillin L-A 1,200,000 units in 2 mL formulations, with a completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Bicillin L-A 1,200,000 units in 2ML vials, with a ceiling value of $2,887.08. This competitive award, issued without a set-aside designation, represents a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The pharmaceutical...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMQAJDelivery Order
The Defense Logistics Agency awarded a $1,535.02 firm fixed price delivery order to AmerisourceBergen Drug Corp for Bicillin L-A 1,200,000 units in 2mL vials, with an ultimate completion date of May 5, 2025. This non-set-aside contract, awarded May 2, 2025, represents a direct purchase of pharmaceutical inventory to support federal healthcare operations. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a prime vendor under this global pharmaceutical support vehicle, AmerisourceBergen supplies critical medications and medical commodities to support military healthcare programs and Defense Health Agency operations worldwide. The company's competitive positioning and extensive federal contract portfolio demonstrate its established capability as a major pharmaceutical distributor serving federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 5/2/25 |